These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33941031)
41. Hyperleptinemia Is a Risk Factor for the Development of Central Arterial Stiffness in Kidney Transplant Patients. Tsai JP; Lee MC; Chen YC; Ho GJ; Shih MH; Hsu BG Transplant Proc; 2015; 47(6):1825-30. PubMed ID: 26293058 [TBL] [Abstract][Full Text] [Related]
42. Relationship between arterial stiffness and chronic kidney disease in patients with primary hypertension. Zuo J; Hu Y; Chang G; Chu SL; Tan I; Butlin M; Avolio A J Hum Hypertens; 2020 Sep; 34(8):577-585. PubMed ID: 31664172 [TBL] [Abstract][Full Text] [Related]
43. Indoxyl Sulfate Impairs Endothelial Progenitor Cells and Might Contribute to Vascular Dysfunction in Patients with Chronic Kidney Disease. Lin CJ; Wu CJ; Wu PC; Pan CF; Wang TJ; Sun FJ; Liu HL; Chen HH; Yeh HI Kidney Blood Press Res; 2016; 41(6):1025-1036. PubMed ID: 28006782 [TBL] [Abstract][Full Text] [Related]
44. Serum Lai YH; Wang CH; Kuo CH; Lin YL; Tsai JP; Hsu BG Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877718 [TBL] [Abstract][Full Text] [Related]
45. Positive correlation of serum adipocyte fatty acid binding protein levels with carotid-femoral pulse wave velocity in geriatric population. Tsai JP; Wang JH; Lee CJ; Chen YC; Hsu BG BMC Geriatr; 2015 Jul; 15():88. PubMed ID: 26205896 [TBL] [Abstract][Full Text] [Related]
46. Serum adiponectin is a negative predictor of central arterial stiffness in kidney transplant patients. Ho CC; Hsu BG; Yin WY; Ho GJ; Chen YC; Lee MC Scand J Clin Lab Invest; 2016; 76(3):264-9. PubMed ID: 26962760 [TBL] [Abstract][Full Text] [Related]
47. Indoxyl sulfate and high-density lipoprotein cholesterol in early stages of chronic kidney disease. Wang L; Xiang F; Ji J; Ding X; Shen B; Chen J; Chen Y; Xue N; Zhang L; Jiang X; Cao X Ren Fail; 2020 Nov; 42(1):1157-1163. PubMed ID: 33191829 [TBL] [Abstract][Full Text] [Related]
48. Cystatin C and arterial stiffness in patients without chronic kidney disease. Piko N; Petreski T; Naji F; Ekart R; Hojs R; Bevc S Clin Nephrol; 2021 Suppl; 96(1):43-48. PubMed ID: 34643490 [TBL] [Abstract][Full Text] [Related]
49. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study. Yang HY; Wu DA; Chen MC; Hsu BG Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685 [TBL] [Abstract][Full Text] [Related]
50. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study. Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738 [TBL] [Abstract][Full Text] [Related]
51. Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease. Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ Am J Med Sci; 2014 May; 347(5):370-6. PubMed ID: 24051956 [TBL] [Abstract][Full Text] [Related]
52. Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease. Krishnasamy R; Hawley CM; Stanton T; Pascoe EM; Campbell KL; Rossi M; Petchey W; Tan KS; Beetham KS; Coombes JS; Leano R; Haluska BA; Isbel NM BMC Nephrol; 2015 Jul; 16():106. PubMed ID: 26187506 [TBL] [Abstract][Full Text] [Related]
54. High serum leptin levels are associated with central arterial stiffness in geriatric patients on hemodialysis. Kuo CH; Lin YL; Wang CH; Lai YH; Syu RJ; Hsu BG Tzu Chi Med J; 2018; 30(4):227-232. PubMed ID: 30305786 [TBL] [Abstract][Full Text] [Related]
55. Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients. Erdan A; Ozkok A; Alpay N; Akkaya V; Yildiz A Int J Artif Organs; 2018 Jul; 41(7):378-384. PubMed ID: 29806514 [TBL] [Abstract][Full Text] [Related]
56. Aortic pulse wave velocity, central pulse pressure, augmentation index and chronic kidney disease progression in individuals with type 2 diabetes: a 3- year prospective study. Liu JJ; Liu S; Lee J; Gurung RL; Yiamunaa M; Ang K; Shao YM; Choo RWM; Tavintharan S; Tang WE; Sum CF; Lim SC BMC Nephrol; 2020 Aug; 21(1):359. PubMed ID: 32819303 [TBL] [Abstract][Full Text] [Related]
57. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease. Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327 [TBL] [Abstract][Full Text] [Related]
58. The Role of Two Heart Biomarkers in IgA Nephropathy. Sági B; Vas T; Jakabfi-Csepregi R; Horváth-Szalai Z; Kőszegi T; Csiky B; Nagy J; Kovács TJ Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373483 [TBL] [Abstract][Full Text] [Related]
59. Relationship between carotid-femoral pulse wave velocity and uric acid in subjects with hypertension and hyperuricemia. Liu J; Wang K; Liu H; Zhao H; Zhao X; Lan Y; Huang W; Wang H Endocr J; 2019 Jul; 66(7):629-636. PubMed ID: 31092739 [TBL] [Abstract][Full Text] [Related]
60. Serum metabolomic profiling and incident CKD among African Americans. Yu B; Zheng Y; Nettleton JA; Alexander D; Coresh J; Boerwinkle E Clin J Am Soc Nephrol; 2014 Aug; 9(8):1410-7. PubMed ID: 25011442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]